NCT05376046View on ClinicalTrials.gov

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2026

Conditions

Sickle Cell DiseaseVaso-occlusive Crisis

Interventions

BIOLOGICAL

Erythrocytic parameters and thrombin generation assay measurement

Erythrocytic parameters and thrombin generation assay measurement

Trial Locations (1)

76000

RECRUITING

Rouen university Hospital, Rouen

All Listed Sponsors

lead

BILLOIR

OTHER